Literature DB >> 10432276

Pneumococcal disease and the role of conjugate vaccines.

D L Klein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10432276     DOI： 10.1089/mdr.1999.5.147

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN： 1076-6294            Impact factor:   3.431


× No keyword cloud information.
  16 in total

1.  Multiplex PCR for identification of seven Streptococcus pneumoniae serotypes targeted by a 7-valent conjugate vaccine.

Authors:  Damien M O'halloran; Mary T Cafferkey
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

2.  Genome sequence of Avery's virulent serotype 2 strain D39 of Streptococcus pneumoniae and comparison with that of unencapsulated laboratory strain R6.

Authors:  Joel A Lanie; Wai-Leung Ng; Krystyna M Kazmierczak; Tiffany M Andrzejewski; Tanja M Davidsen; Kyle J Wayne; Hervé Tettelin; John I Glass; Malcolm E Winkler
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

3.  Immunization with PspA incorporated into a poly(ethylene oxide) matrix elicits protective immunity against Streptococcus pneumoniae.

Authors:  Quincy C Moore; LaShundra Johnson; Michael Repka; Larry S McDaniel
Journal:  Clin Vaccine Immunol       Date:  2007-04-25

4.  Surveillance of invasive Streptococcus pneumoniae infection in the province of Quebec, Canada, from 1996 to 1998: serotype distribution, Antimicrobial susceptibility, and clinical characteristics.

Authors:  L P Jetté; G Delage; L Ringuette; R Allard; P De Wals ; F Lamothe; V Loo
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

5.  Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis.

Authors:  J E Adamou; J H Heinrichs; A L Erwin; W Walsh; T Gayle; M Dormitzer; R Dagan; Y A Brewah; P Barren; R Lathigra; S Langermann; S Koenig; S Johnson
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

6.  PCR-based ordered genomic libraries: a new approach to drug target identification for Streptococcus pneumoniae.

Authors:  Aimee E Belanger; Angel Lai; Marcia A Brackman; Donald J LeBlanc
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 7.  Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection.

Authors:  Malcolm J M Darkes; Greg L Plosker
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

8.  Phenotypic characterization of Streptococcus pneumoniae biofilm development.

Authors:  Magee Allegrucci; F Z Hu; K Shen; J Hayes; Garth D Ehrlich; J Christopher Post; Karin Sauer
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

9.  Pneumococcal surface protein A is expressed in vivo, and antibodies to PspA are effective for therapy in a murine model of pneumococcal sepsis.

Authors:  E Swiatlo; J King; G S Nabors; B Mathews; D E Briles
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

10.  Genome evolution driven by host adaptations results in a more virulent and antimicrobial-resistant Streptococcus pneumoniae serotype 14.

Authors:  Feng Ding; Petrus Tang; Mei-Hua Hsu; Peng Cui; Songnian Hu; Jun Yu; Cheng-Hsun Chiu
Journal:  BMC Genomics       Date:  2009-04-13       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.